All Deals

Latest News

• Supriya Lifescience share price soars 7% in weak market today; here's why (02 Jan 2025)

  Supriya Lifescience Chairman and Whole-Time Director Satish Wagh said he was confident of achieving 22 per cent year-on-year revenue growth...

• Supriya Lifescience expects new capacities to drive growth (02 Jan 2025)

  Satish Wagh, Chairman and Whole-Time Dir, Supriya Lifescience, stated that it has invested ₹250 crore across two plants,...

• Supriya Lifescience MD Saloni Wagh on adding capacity, topline target and more (27 Dec 2024)

  Bulk-drugs maker Supriya Lifescience Ltd, which was founded in 1987 and operates in therapeutic segments such as ...

• Supriya Lifescience Confident Of Beating FY25 Margin Guidance, Maintaining Momentum In Long Term (22 Dec 2024)

  Supriya Lifescience expects to exceed FY25 margin guidance and achieve Rs 1000-crore revenue by FY27, driven by regulated markets and...

• Supriya Lifescience Inaugurates New API Block in Maharashtra | (21 Dec 2024)

  Supriya Lifescience has inaugurated a state-of-the-art multipurpose API production block at its Lote Parshuram site in Maharashtra.

• Supriya Lifescience inaugurates Rs 125 crore API production block at Lote Parshuram site (20 Dec 2024)

  Mumbai: Supriya Lifescience Ltd has inaugurated its new multipurpose Active Pharmaceutical Ingredients (APIs) production block, Module E,...

• Supriya Lifescience Limited (NSE:SUPRIYA) Top Key Executive Satish Wagh's holdings dropped 6.9% in value as a result of the recent pullback (18 Dec 2024)

  Key Insights Supriya Lifescience's significant insider ownership suggests inherent interests in company's expansion 68...

• Supriya Lifesciences jumps 6% after co expands capacity at API unit (18 Dec 2024)

  Supriya Lifesciences share price surged after the company inaugurated a new active pharmaceutical ingredients (APIs) production block,...

• Supriya Lifescience Ltd Inaugurates State-of-the-Art Module E Production Block at Lote Parshuram, Maharashtra (18 Dec 2024)

  New Delhi, 18th December 2024: Supriya Lifescience Ltd (SLL), a leader in the pharmaceutical industry, has taken another significant step on...

• Supriya Lifescience Stock Rises 5.29% Amid Market Decline on December 18, 2024 (18 Dec 2024)

  **Supriya Lifescience Sees Notable Gains Amid Market Fluctuations** On December 18, 2024, Supriya Lifescience, a midcap player in the...

• SUPRIYA LIFESCIENCE Share Price Today Up 5% (18 Dec 2024)

  Real-time updates on SUPRIYA LIFESCIENCE share price. Check out the detailed analysis of the company in this live blog.

• Supriya Lifescience opens new API block at Lote Parshuram site in Maharashtra (17 Dec 2024)

  Supriya Lifescience inaugurated a new API production facility in Maharashtra, costing Rs 120 crore. The expansion adds 335 kiloliters of...

• Supriya Lifescience inaugurates Rs. 125 crore new API production block in Maharashtra (17 Dec 2024)

  The facility houses 33 reactors, comprising stainless steel and glass-lined varieties, with capacities ranging from 1.6 KL to 16 KL.

• Supriya Lifescience inaugurates new API production block at Lote Parshuram site (17 Dec 2024)

  Supriya Lifescience inaugurated its new multipurpose Active Pharmaceutical Ingredients (APIs) production block, Module E, at the Lote...

• Supriya Lifescience Stock Downgraded to 'Hold' by MarketsMOJO Amid Mixed Performance (16 Dec 2024)

  **Supriya Lifescience Stock Downgraded to 'Hold' by MarketsMOJO** Supriya Lifescience, a midcap player in the pharmaceuticals and drugs...

• Supriya Lifescience - These 11 healthcare stocks have more than doubled investors' wealth in CY24 (11 Dec 2024)

  The stock has advanced by 145% in CY24, from Rs 315 to Rs 770. Supriya Lifescience.

• Supriya Lifescience expands global footprint with Esketamine Hydrochloride approval, Atorvastatin patent... (11 Dec 2024)

  Mumbai: Supriya Lifescience Ltd. has acquired approval from Brazil's health authority, ANVISA (Agência Nacional de Vigilância Sanitária),...

• Supriya Lifescience Expands Global Footprint With Esketamine Hydrochloride Approval & Atorvastatin Patent Filing. (10 Dec 2024)

  Mumbai, 9th of December, 2024 : Supriya Lifescience Ltd., a global pharmaceutical industry leader, achieved two significant milestones,...

• Supriya Lifescience gains ANVISA nod for Esketamine Hydrochloride & files patent for Atorvastatin development (10 Dec 2024)

  Supriya Lifescience has acquired approval from Brazil's health authority, ANVISA (Agência Nacional de Vigilância Sanitária), for Esketamine...

• Supriya Lifescience Expands with Esketamine Approval & Atorvastatin Patent (10 Dec 2024)

  December 10, 2024: Supriya Lifescience Ltd., a global pharmaceutical industry leader, achieved two significant milestones, strengthening its...

• STOCKS IN NEWS: Nbcc, Bajaj Finserv, Glenmark Pharms, Indraprastha Gas, Syngene Inter, Bharat Forge, Tiger Logistics India, Metropolis Healthcare, Greaves Cotton, Brookfield India Real Estate Trust, Supriya Lifescience, BEL, PFC, NHPC and others (10 Dec 2024)

  NBCC Bags ₹432 Crore Order for Net-Zero Campus at Central University of Odisha (News on: 12/10/2024) NBCC (India) Ltd has secured a ₹432...

• Supriya Lifescience expands global footprint with Esketamine Hydrochloride approval & Atorvastatin patent filing (10 Dec 2024)

  Mumbai : Supriya Lifescience Ltd., a global pharmaceutical industry leader, achieved two significant milestones, strengthening its position...

• Supriya Lifescience’s Blood Donation Drive Receives Overwhelming Support: 1,790 Donors Join To Save Lives. (09 Dec 2024)

  Mumbai, 8th of December, 2024 : In a landmark initiative underscoring its commitment to healthcare and social responsibility, Supriya...

• Supriya Lifescience gets Brazil approval for mental illness drug, files patent for heart & cholestrol medicine (09 Dec 2024)

  Shares of Supriya Lifescience Ltd ended at ₹783.10, up by ₹8.95, or 1.16% on the BSE.

• Supriya Lifescience expands global footprint with Esketamine Hydrochloride approval (09 Dec 2024)

  Esketamine hydrochloride is a vital drug to be used for treating mental illness and is likely to significantly impact the LATAM market.

• Supriya Lifescience Gets Brazils Nod For Mental Illness Drug (09 Dec 2024)

  Supriya Lifescience Ltd. gained entry into Brazil's pharmaceutical market through getting approval for Esketamine Hydrochloride from...

• Supriya Lifescience standalone net profit rises 93.26% in the September 2024 quarter (09 Dec 2024)

  Net profit of Supriya Lifescience rose 93.26% to Rs 46.15 crore in the quarter ended September 2024 as against Rs 23.88 crore during the previous quar...

• Supriya Lifescience Gets Brazil's Nod For Mental Illness Drug (09 Dec 2024)

  Supriya Lifescience Ltd. gained entry into Brazil's pharmaceutical market through getting approval for Esketamine Hydrochloride from...

• Supriya Lifescience’s Blood Donation Drive Receives Overwhelming Support: 1,790 Donors Join to Save Lives (07 Dec 2024)

  Mumbai – In a landmark initiative underscoring its commitment to healthcare and social responsibility, Supriya Lifescience Ltd. organised a...

• Supriya Lifescience - MF-backed stocks: 7 counters surge up to 200% in CY24 (06 Dec 2024)

  The stock has surged 147%, rising from Rs 315 to Rs 778 in CY24 so far. Supriya Lifescience.

• Supriya Lifescience - 8 healthcare stocks delivered multibagger returns in FY25. Do you own any? (26 Nov 2024)

  The stock has gained 139% in FY25, climbing to Rs 792 from Rs 332. Supriya Lifescience.

• SUPRIYA LIFESCIENCE Share Price Today Up 6% (22 Nov 2024)

  Real-time updates on SUPRIYA LIFESCIENCE share price. Check out the detailed analysis of the company in this live blog.

• Trade Spotlight: How should you trade IGL, Tata Steel, Fortis Healthcare, Uno Minda, Supriya Lifescience, NALCO, and others on Thursday? (21 Nov 2024)

  The market may extend its upward move amid consolidation in the upcoming session, but the.

• Trade Spotlight: How should you trade IGL, Tata Steel, Fortis Healthcare, Uno Minda, Supriya Lifescience,... (21 Nov 2024)

  The market may extend its upward move amid consolidation in the upcoming session, but the.

• Supriya Lifescience's Stock Reaches All-Time High, Outperforms Sector and Sensex (21 Nov 2024)

  Supriya Lifescience, a midcap pharmaceutical company, has been making waves in the stock market with its recent performance. On November 20, 2024,...

• Supriya Lifescience's Stock Soars, Outperforms Sector and Sensex in Recent Surge (20 Nov 2024)

  Supriya Lifescience, a midcap pharmaceutical company, has been making waves in the stock market with its recent performance.

• Supriya Lifescience's Stock Reaches All-Time High, Rated as 'Buy' by MarketsMOJO (20 Nov 2024)

  Supriya Lifescience, a midcap pharmaceutical company, has been making waves in the stock market with its recent performance. On November 19, 2024,...

• Supriya Lifescience Reports Strong Financial Results for Q3 2024, Receives 'Buy' Rating (20 Nov 2024)

  Supriya Lifescience, a midcap pharmaceutical company, has recently announced its financial results for the quarter ending September 2024.

• Supriya Lifescience Limited (NSE:SUPRIYA) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected (07 Nov 2024)

  Supriya Lifescience Limited ( NSE:SUPRIYA ) shares have continued their recent momentum with a 26% gain in the last...

• Supriya Lifescience Ltd. Reports Strong Q2 FY25 Growth With 19% YoY Revenue Increase (07 Nov 2024)

  The unaudited financial statements for the Q2FY25 results have been released by Supriya Lifescience Ltd., a cGMP-compliant business with a...

• Supriya Lifescience Stock Sees 6.54% Increase, Outperforms Sector and Market (06 Nov 2024)

  Supriya Lifescience, a midcap pharmaceutical company, saw a 6.54% increase in its stock price on November 6, 2024.

• Supriya Lifescience's Stock Reaches 52-Week High, Outperforms Sector by 5.38% (06 Nov 2024)

  Supriya Lifescience, a midcap pharmaceutical company, has recently seen a surge in its stock price, reaching a 52-week high on November 6th, 2024.

• Supriya Lifescience Reaches All-Time High, Outperforms Sector with Strong Growth (06 Nov 2024)

  Supriya Lifescience, a midcap pharmaceutical company, has recently reached an all-time high in its stock price on November 6th, 2024.

• Supriya Lifescience's Stock Price Rises by 5.68% on November 5th, Outperforms Sector and Sensex (05 Nov 2024)

  Supriya Lifescience, a midcap pharmaceutical company, saw a 5.68% increase in its stock price on November 5th, 2024.

• Supriya Lifescience reports 19% revenue increase in Q2 FY25 (01 Nov 2024)

  The company reported a net profit of Rs 46.15 crore in Q2 FY25 as compared to Rs 23.88 crore in Q2 FY24.

• Supriya Lifescience Second Quarter 2025 Earnings: EPS: ₹5.71 (vs ₹2.97 in 2Q 2024) (30 Oct 2024)

  Supriya Lifescience ( NSE:SUPRIYA ) Second Quarter 2025 Results Key Financial Results Revenue: ₹1.69b (up 20% from 2Q...

• Supriya Lifescience's Stock Soars with 5.04% Gain, Outperforming Sector by 5.9% (30 Oct 2024)

  Supriya Lifescience, a midcap pharmaceutical company, has been making waves in the stock market with its recent performance.

• Buy Supriya Lifescience; target of Rs 644: KR Choksey (30 Oct 2024)

  KR Choksey is bullish on Supriya Lifescience has recommended buy rating on the stock with a target price of Rs 644 in its research report...

• Supriya Lifescience Ltd. Sees 19% YoY Revenue Surge in Q2 FY25, Signaling Robust Growth (30 Oct 2024)

  Mumbai, 30th October 2024: The unaudited financial statements for the Q2FY25 results have been released by Supriya Lifescience Ltd.,...

• Supriya Lifescience Ltd. Reports Strong Q2 FY25 Growth With 19% Yoy Revenue Increase. (29 Oct 2024)

  Mumbai, 29th of October, 2024 : The unaudited financial statements for the Q2FY25 results have been released by Supriya Lifescience Ltd., a cGMP-compliant...

• Supriya Lifesci Standalone September 2024 Net Sales at Rs 166.10 crore, up 18.56% Y-o-Y (29 Oct 2024)

  Net Sales at Rs 166.10 crore in September 2024 up 18.56% from Rs. 140.10 crore in September 2023. Story continues below Advertisement.

• SUPRIYA LIFESCIENCE Share Price Today Up 4% (29 Oct 2024)

  Real-time updates on SUPRIYA LIFESCIENCE share price. Check out the detailed analysis of the company in this live blog.

• India's Supriya Lifescience gains on strong Q2 results (29 Oct 2024)

  ... ** Shares of Supriya Lifescience SPRL.NS climb 4% to 576 rupees; set for fifth straight session of gains.

• Supriya Lifescience Q2 Revenue Up 19%, Driven By Anaesthetic Segment (29 Oct 2024)

  Supriya Lifescience, a leading manufacturer of active pharmaceutical ingredients (APIs), revealed robust financial results for Q2 FY25,...

• Pharma stock jumps 8% after the company reports 93% YoY increase in net profits (29 Oct 2024)

  Small-cap pharma stock, involved in the engaged in manufacturing and export of active pharmaceutical ingredients, surged 8.5 percent...

• From Dreams to Reality: The Remarkable Entrepreneurial Journey of Dr. Satish Wagh in the Pharmaceutical Industry (25 Oct 2024)

  Dr. Satish Wagh's journey is a remarkable testament to ambition and resilience. For him, dreams held more value than wealth.

• Supriya Lifesciences to hold AGM (02 Oct 2024)

  Supriya Lifesciences announced that the Annual General Meeting (AGM) of the company will be held on 27 September 2024.

• Supriya Life Challenges Chinas Dominance On Drug Ingredients For Topline Boost (20 Sep 2024)

  Supriya Lifesciences Ltd. is on track to take on the dominance of Chinese drug manufacturers with the launch of its new active...

• Supriya Lifescience Reaches All-Time High, Outperforms Sector and Market (20 Sep 2024)

  Supriya Lifescience, a midcap pharmaceutical company, has recently reached an all-time high in its stock price on September 16, 2024.

• 5:34 / 16:05 Supriya Lifescience: Total Capacity To Rise From 597 KL To 900 KL By Q2 (19 Sep 2024)

  5:34 / 16:05 Supriya Lifescience: Total Capacity To Rise From 597 KL To 900 KL By Q2.

• Interview with Shivani Wagh, Joint Managing Director, Supriya Lifescience Ltd (11 Sep 2024)

  In this insightful interview, Shivani Wagh, Joint Managing Director of Supriya Lifescience Ltd, discusses the company's recent impressive...

• Supriya Lifescience (NSE:SUPRIYA) Has Announced That It Will Be Increasing Its Dividend To ₹0.80 (08 Sep 2024)

  The board of Supriya Lifescience Limited ( NSE:SUPRIYA ) has announced that it will be paying its dividend of ₹0.80 on...

• Supriya Lifesci Standalone June 2024 Net Sales at Rs 160.63 crore, up 21.67% Y-o-Y (02 Sep 2024)

  Reported Standalone quarterly numbers for Supriya Lifescience are: Net Sales at Rs 160.63 crore in June 2024 up 21.67% from Rs. 132.02 crore in June 2023.

• Supriya Lifescience share price skyrockets 8% to 52-week high: Nearly doubles in a year as Europe sales gain traction | Stock Market News (19 Aug 2024)

  Stock Market Today: Supriya Lifescience share price rises 8% to 52-week high during the intraday trades. The stock that closed at ₹532.15...

• Latest Market News Today Live Updates August 19, 2024: Supriya Lifescience share price skyrockets 8% to 52-week high: Nearly doubles in a year as Europe sales gain traction | Stock Market News (19 Aug 2024)

  Latest Market News Today Live Updates: Catch today's market wrap-up! Track Nifty 50 and Sensex movements, along with top gainers and losers.

• Buy Supriya Lifescience; target of Rs 578: KR Choksey (14 Aug 2024)

  KR Choksey is bullish on Supriya Lifescience has recommended buy rating on the stock with a target price of Rs 578 in its research report...

• Supriya Life-Science reports robust Q1 FY25 results with 21.7% revenue growth & enhanced profit margins (14 Aug 2024)

  Jammu Tawi: The financial statements for the first quarter of Q1 FY 25 have been released by Supriya Life-science Ltd., a cGMP-compliant business with a.

• Supriya Lifescience Reports Robust Q1 FY25 Results With 21.7% Revenue Growth & Enhanced Profit Margins. (14 Aug 2024)

  Mumbai, 13th of August 2024: The financial statements for the first quarter of Q1 FY 25 have been released by Supriya Lifescience Ltd.,...

• Supriya Lifescience Reports Robust Q1 FY25 Results With 21.7% Revenue Growth & Enhanced Profit Margins (14 Aug 2024)

  The financial statements for the first quarter of Q1 FY 25 have been released by Supriya Lifescience Limited, a cGMP-compliant business with...

• Supriya Lifescience Limited Reports Earnings Results for the First Quarter Ended June 30, 2024 (14 Aug 2024)

  Supriya Lifescience Limited reported earnings results for the first quarter ended June 30, 2024. For the first quarter, the company reported...

• Supriya Lifescience reports 21.7 per cent Y-o-Y revenue increase in Q1 FY24 (13 Aug 2024)

  Mumbai: The financial statements for the first quarter of Q1 FY 25 have been released by Supriya Lifescience Ltd, a cGMP-compliant business...

• Supriya Lifescience reports robust Q1 FY25 results with 21.7% revenue growth (13 Aug 2024)

  European markets now contribute 51% of our business revenue up from 43% in Q4 FY24 and 34% in Q1 FY24.

• Technical picks: Bajaj Auto, Godfrey Phillips among 5 stocks that can rally up to 35% in short-term (12 Aug 2024)

  Buy at Rs: 450Stop Loss: Rs 400Target Price: Rs 500-550Upside: 22%The stock has recently been ready for an ascending triangle breakout on...

• Supriya Lifescience First Quarter 2025 Earnings: EPS: ₹5.54 (vs ₹3.54 in 1Q 2024) (12 Aug 2024)

  Supriya Lifescience ( NSE:SUPRIYA ) First Quarter 2025 Results Key Financial Results Revenue: ₹1.63b (up 23% from 1Q...

• Supriya Lifescience standalone net profit rises 56.58% in the June 2024 quarter (12 Aug 2024)

  Net profit of Supriya Lifescience rose 56.58% to Rs 44.64 crore in the quarter ended June 2024 as against Rs 28.51 crore during the previous quarter ended...

• Supriya Lifescience - Technical picks: Bajaj Auto, Godfrey Phillips among 5 stocks that can rally up to 35% in short-term (12 Aug 2024)

  Buy at Rs: 450Stop Loss: Rs 400Target Price: Rs 500-550Upside: 22%The stock has recently been ready for an ascending triangle breakout on...

• Market Trading Guide: Bajaj Auto, NBCC among 6 stock recommendations for Monday (11 Aug 2024)

  Target Price: Rs 500-550 Stop Loss: Rs 400The stock has recently been ready for an ascending triangle breakout on the daily chart with a...

• Urgent need for stringent adherence to international quality standards to boost exports: Shivani Wagh (08 Aug 2024)

  Urgent need for stringent adherence to international quality standards to boost exports: Shivani Wagh. Shardul Nautiyal, Mumbai

• Dr Saloni Wagh named MD, Shivani Wagh as joint MD & Dr Satish Wagh as executive chairman of Supriya Lifescience (05 Aug 2024)

  Dr Saloni Wagh named MD, Shivani Wagh as joint MD & Dr Satish Wagh as executive chairman of Supriya Lifescience. Our Bureau, Mumbai

• Supriya Lifesciences announces new appointees to key leadership positions (05 Aug 2024)

  Supriya Lifescience announces the appointment of Dr Saloni Wagh as Managing Director, and Shivani Satish Wagh as the Joint Managing Director...

• Supriya Lifescience Ltd. Strengthens Leadership: Dr. Saloni Wagh Named Managing Director, Ms. Shivani Wagh As Joint Managing Director, & Dr. Satish Wagh As Executive Chairman. (03 Aug 2024)

  Mumbai, 2nd of August, 2024 : Supriya Lifescience Ltd., a global leader in the manufacturing of Active Pharmaceutical Ingredients (APIs),...

• Supriya Lifescience names Dr. Saloni Wagh as MD (03 Aug 2024)

  Supriya Lifescience Ltd., a global leader in the manufacturing of Active Pharmaceutical Ingredients (APIs), is embarking on an exciting new...

• Supriya Lifescience Ltd appoints Dr Saloni Wagh as MD , Shivani Wagh as Joint MD, Dr Satish Wagh as Executiv.. (02 Aug 2024)

  Peoples Movement: Dr Saloni has played an integral role in Supriya Lifescience's success and growth, particularly in terms of revenue.

• Supriya Lifescience promoter Wagh family’s next-gen to helm company (02 Aug 2024)

  Supriya Lifescience promotes next-gen Wagh family members to key roles, focusing on innovation and global growth in pharmaceuticals.

• Supriya Lifescience Ltd appoints Dr Saloni Wagh as MD , Shivani Wagh as Joint MD, Dr Satish Wagh as Executive Chairman (02 Aug 2024)

  Supriya Lifescience Ltd appoints Dr Saloni Wagh as MD , Shivani Wagh as Joint MD, Dr Satish Wagh as Executive Chairman. Dr Saloni has played an...

• [100 Emerging Women Leaders] How Saloni Wagh is steering Supriya Lifescience on a forward path (30 Jul 2024)

  Saloni Wagh started her career as a marketing assistant at her family-run business, Supriya Lifescience, 10 years ago.

• Union Budget quote from Dr. Saloni Wagh, Director, Supriya Lifescience Ltd (25 Jul 2024)

  “This budget represents a pivotal move towards a Vikasit Bharat, emphasizing progress through targeted support for Garib (poor),...

• Quote On Union Budget 2024-25 : Dr. Saloni Wagh, Director, Supriya Lifescience. (24 Jul 2024)

  Mumbai, Maharashtra 23rd of July, 2024 : “This budget represents a pivotal move towards a Vikasit Bharat, emphasizing progress through targeted support for...

• The Rise Of Supriya Lifescience : A Comprehensive Company Profile. (02 Jul 2024)

  Mumbai, 21st of June, 2024 : What is the Supriya Life science's outlook for next 5 years? Supriya Lifescience Ltd. intends to significantly...

• Buy Supriya Lifescience; target of Rs 401: KR Choksey (02 Jul 2024)

  KR Choksey's research report on Supriya Lifescience. Supriya Life science's revenue beat our estimate (+5.8%) due to growth in Vitamin and...

• Our primary goal is to double our revenue, enter higher-margin niche segments and increase footprint: Dr. Saloni Wagh, Director, Supriya Lifescience Ltd. (24 Jun 2024)

  Our strategic goals include increasing our footprint in these regulated markets, enhancing our North American contributions, and expanding...

• Supriya Lifesci Standalone March 2024 Net Sales at Rs 158.18 crore, up 11.18% Y-o-Y (28 May 2024)

  Quarterly Net Profit at Rs. 36.93 crore in March 2024 down 3.39% from Rs. 38.23 crore in March 2023. EBITDA stands at Rs. 57.69 crore in...

• Supriya Lifescience Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 (28 May 2024)

  Supriya Lifescience Limited reported earnings results for the fourth quarter and full year ended March 31, 2024. For the fourth quarter,...

• CSR initiative donates 14-seater vehicle for Mumbai's Sanjay Gandhi National Park Tiger Safari (12 Apr 2024)

  Mumbai, India: Supriya Lifescience Limited, a global leader in the manufacturing of Active Pharmaceutical Ingredients (APIs),...

• Is Supriya Lifescience Limited's (NSE:SUPRIYA) Recent Stock Performance Tethered To Its Strong Fundamentals? (04 Apr 2024)

  In Supriya Lifescience's case, its respectable earnings growth can probably be explained by its low three-year median payout ratio of 3.0% (or a...

• Supriya Lifescience Share Price (28 Mar 2024)

  The company was incorporated as Supriya Lifescience Limited on 26 March 2008 upon the conversion of M/s Supriya Chemicalsa partnership firm into a public...

• Pharma will be a major contributor to India's economy: Dr Satish Wagh, Chairman & MD, Supriya Lifescience (28 Mar 2024)

  Dr. Satish Wagh, Chairman & MD, Supriya Lifescience speaks to Express Pharma on the company's strategy to achieve a turnover of INR 1000...

• Supriya Lifescience Ltd (28 Mar 2024)

  The company was incorporated as Supriya Lifescience Limited on 26 March 2008 upon the conversion of M/s Supriya Chemicalsa partnership firm into a public...

• Supriya Lifescience champions women's integral role in India's USD 5 trillion ambition (11 Mar 2024)

  Supriya Lifescience champions women's integral role in India's USD 5 trillion ambition. Our Bureau, Mumbai Monday, March 11, 2024,...

• Supriya Lifescience expects to double revenue to Rs 1,000 crore in next 3 years (08 Mar 2024)

  Supriya Lifescience aims to double revenue to Rs 1000 crore by venturing into higher-margin niche segments. Led by Satish Wagh,...

• In an interaction with Dr Saloni Wagh, Director of Supriya Lifescience Ltd (08 Mar 2024)

  Establishing a strong regulatory framework and maintaining compliance with relevant regulations is paramount for success in the...

• How Supriya Lifescience is performing in a growth-constrained pharma sector (03 Mar 2024)

  The company, which went public with a ₹ 700 crore initial offer (IPO) in 2021, is now looking at custom-development and manufacturing (CDM)...

• Supriya Lifescience Aims To Double Revenue To Rs 1,000 Crore By FY27 — Know Your Company (26 Feb 2024)

  Supriya Lifesciences Ltd. expects Rs 1000 crore in revenue by FY27, according to Chief Financial Officer Krishna Raghunathan.

• Supriya Lifescience wins 8 gold awards at Maharashtra State Export and MOU Signing Awards (14 Feb 2024)

  Supriya Lifescience Ltd, a prominent player in the active pharmaceutical ingredient (API) manufacturing sector, has achieved a significant...

• Supriya Lifescience wins 8 Golds (13 Feb 2024)

  API manufacturer Supriya Lifescience Limited has secured eight Gold awards at The Government of Maharashtra's State Export and MOU Signing...

• Supriya Lifesciences targets Brazil, eyes Rs 200 crore sales in 2-3 years (11 Jan 2024)

  This ambition follows the company's recent approval from Anvisa (Brazilian health regulatory agency), which has facilitated its entry into...

• Supriya Lifesciences received GMP certification from ANVISA Brazil (06 Jan 2024)

  Supriya Lifescience Limited has announced that its manufacturing site in Lote Parshuram has received Good Manufacturing Practice (GMP)...

• Supriya Lifescience Limited Signs Agreement With Kalinga Institute Of Technology For Further Development Of Wound Healing Gel (06 Nov 2023)

  Supriya Lifescience Limited Signs Agreement With Kalinga Institute Of Technology For Further Development Of Wound Healing Gel.

• Supriya Life Sciences Share Price Today - Supriya Life Sciences Stock Price Live NSE/BSE (26 Oct 2023)

  Supriya Life Sciences Share Price Today - 5 Sep 2024: Find Supriya Life Sciences Stock Price Live updates on Mint. Check out Supriya Life Sciences share...

• Supriya Life targets 1-2% global mkt share with oral cancer detection kit (23 Oct 2023)

  Supriya Life Share: Quickblue is designed to detect oral cancer swiftly, eliminating the need for extensive preclinical and clinical trials.